Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Bank of America Corp (BAC) Having a CCAR Hangover Today? – Citigroup Inc. (C), JPMorgan Chase & Co. (JPM)

Last week saw a party-hearty atmosphere for the overall market, and financials in particular. No doubt this was due to the star turns put in by Bank of America Corp (NYSE:BAC) and Citigroup Inc. (NYSE:C) on the stress tests and Comprehensive Capital Analysis and Review, in which both banks strutted their capital strength.

Bank of America Corp (NYSE:BAC)

After all the revelry, this morning finds both the Dow and the S&P 500 looking sickly as they both continue with the slippage begun last Friday. For banks, most have what seems to be the equivalent of a Monday morning hangover as they slide downward, regardless of their respective grades on the Federal Reserve’s tests.

For JPMorgan Chase & Co. (NYSE:JPM) and Goldman Sachs Group, Inc. (NYSE:GS) , the plunge is somewhat expected, since both banks will be required to tweak their capital plans and resubmit them to the Fed. But what about Citigroup Inc. (NYSE:C) and Bank of America Corp (NYSE:BAC)? Why are they looking so green around the gills today?

Capital plans approved
Both banks were given the go-ahead to pursue stock repurchases but did not request a dividend raise. While Citi’s $1.2 billion buyback plan is respectable, B of A will be buying up an astounding $10.5 billion in outstanding shares — and that, combined with other issues, may be at the root of its lethargy so far today.

While a buyback is surely a good thing for investors, the excitement over the Fed test win may be becoming blunted now as the realization that there will be no dividend raise starts to sink in. In addition, more than half of the shares to be repurchased are of the preferred variety.

This is good for all investors, since those shares, unlike common stock, do get a nice payout. But investors may see this move as B of A trying to pay back an emergency infusion of cash from a high-profile investor rather than rewarding the regular Joes and Janes. Can you say “Warren Buffett”?

At any rate, trading is heavy in Bank of America today, and the week is young. Perhaps the hangover will wear off, to be replaced with a well-earned appreciation for just how far the bank has come in the past year. After all, as Foolish, long-term investors, we recognize the need to keep the one-day jumps and jives of a stock in perspective. Even stocks have good days and bad days, so it’s important to realize that sometimes they’re not portents of dire news, but merely squiggles that we can safely ignore.

The article Is Bank of America Having a CCAR Hangover Today? originally appeared on and is written by Amanda Alix.

Fool contributor Amanda Alix has no position in any stocks mentioned. The Motley Fool recommends Goldman Sachs. The Motley Fool owns shares of Bank of America, Citigroup, and JPMorgan Chase.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.